You've successfully subscribed to Warp News
Great! Next, complete checkout for full access to Warp News
Welcome back! You've successfully signed in.
Thank you! Check your email inbox to activate your account.
Success! Your billing info is updated.
Billing info update failed.
πŸ’‰ First peer-reviewed trial showing that a COVID-19 vaccine produces antibodies to the virus

πŸ’‰ First peer-reviewed trial showing that a COVID-19 vaccine produces antibodies to the virus

The race to find a vaccine against COVID-19 has taken a big step forward. the first experiment that has undergone a peer review has shown that vaccines produce antibodies against the virus.

Per Pettersson
Per Pettersson

The race to find a vaccine against COVID-19 has been going on since the beginning of the year. Several different vaccine candidates are under development and being tested in different ways. Now, the first trial that has undergone a peer review has shown that a vaccine candidate produces antibodies to the virus.

Many previous trials that have shown promising results have been difficult to verify. Sometimes details about the experiments have been missing, often they have been performed on animals. What distinguishes this experiment is that it passed through review before publication and that it was performed on humans. The study included 45 adults, aged 18-55 years.

The study shows that the vaccine seems to provide better protection than just undergoing the disease, which is good news for the development of vaccines. This shows that vaccines should work to stop COVID-19 and that they may not be as far away as feared.

Like all vaccines, there are some side effects in some individuals in the study. These include chills, fatigue, headaches and muscle aches. However, all were transient.

So far, it is too early to say that the vaccine is definitely the answer to the virus and the question of course remains how strong the protection is and how long it lasts. However, the results are promising.

Photo by Vincent Ghilione on Unsplash

πŸ“ Get a weekly dose of fact-based optimism right in your inbox every week.

Join over 15,000 optimistic, forward-looking subscribers who are making a better and more prosperous future come sooner.